Key facts
- This page summarizes Robert B. Catell's Form 4 filing for APPLIED DNA SCIENCES INC (APDN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Oct 2025, 17:04.
Robert B. Catell - 17 Oct 2025 Form 4 Insider Report for APPLIED DNA SCIENCES INC (APDN)
- Reporting relationship
- Director
- Issuer ticker
- APDN
- Reported as of
- 17 Oct 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Oct 2025, 17:04:37 UTC
- Prior SEC filing
- 27 Jan 2023
- Next SEC filing
- 31 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Beth Jantzen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert B. Catell filed Form 4 for APPLIED DNA SCIENCES INC (APDN) on 20 Oct 2025.
Change
- Previous filing in this sequence was filed on 27 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001195325
Primary reporting owner
CATELL ROBERT B
- Relationship
- Director
- Address
- 50 HEALTH SCIENCES DRIVE, STONY BROOK
- Signature
- /s/ Beth Jantzen, Attorney-in-Fact
- Signature date
- 20 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BNBX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +22,511
- Change %
- +2251100%
- Price
- $0.000000
- Shares after
- 22,512
- Date
- 17 Oct 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
100% of the restricted stock units vest upon 90 days from the date of grant